Today on DrugResearcher.com   Second new class of HIV drug given thumbs up AstraZeneca to help Biovator replace in vivo allergy testing BioVascular, Revitus join forces to target vascular disease Imaging protease activity MS drugs to drive Biogen long-term growth

Related Industry News   Crospon to make drug delivery smarter Biotest scoops up ailing Nabi's biologics unit FDA probe ghost stops haunting MDS Pharma Averion ventures into Brazil

Breaking News on Drug Discovery
Daily  Tuesday 11 September 2007		Forward to a colleague

	Access Full Stories Second new class of HIV drug given thumbs up Merck & Co.'s integrase inhibitor, the first in a new class of HIV drug, looks likely to win approval in the near future, following a recommendation to regulators... Read AstraZeneca to help Biovator replace in vivo allergy testing AstraZeneca (AZ) is to assist Biovator in the development of its in vitro test for identifying potential allergens that could replace many experiments on animals... Read BioVascular, Revitus join forces to target vascular disease Two privately held biotech companies developing compounds to prevent blood clots have merged as their second drug candidate enters clinical trials... Read Imaging protease activity US researchers have developed a molecular probe that can light up tumour cells within living animals and enable direct imaging of cysteine protease activity... Read MS drugs to drive Biogen long-term growth In a presentation to investors, Biogen Idec has announced it expects its MS drugs to fuel a 15 per cent annual growth in revenue in the next three years... Read
	All News Headlines for: September | August | July
	Event Don't miss SMi's Drug Delivery Global Summit! This is a must-attend event for all those involved in addressing the growing challenges in the drug delivery field. The conference features an excellent opportunity to hear from an international panel of experts, including Bruce M Pratt, Vice President, Science Development, Genzyme... Click Here
	Related Industry News Crospon to make drug delivery smarter Irish start-up Crospon has licensed a 'smart' drug delivery skin patch technology from HP Labs that uses inkjet printing technology to deliver drugs under the skin... Read Biotest scoops up ailing Nabi's biologics unit German firm Biotest has bought up Nabi Biopharmaceuticals biologics division in a multi-million Euro deal, less than three months after the unit was created following Nabi restructuring efforts... Read FDA probe ghost stops haunting MDS Pharma It seems that the ghost of the US Food and Drug Administration (FDA) probe has stopped haunting MDS Pharma as the firm posted encouraging financial results in the third quarter... Read Averion ventures into Brazil Averion has formed a new partnership in South America's clinical trial hotspot Brazil - as it continues to tip-toe beyond North America and Europe into emerging markets... Read Weekly comment Chinese scientists given freedom to fail As part of a drive towards greater innovation, the Chinese government looks set to introduce new laws giving its domestic scientists freedom to tackle complex scientific problems without fear of failure, according to a state media report this week. Read Previous Headlines Erectile dysfunction drug deemed a flop King Pharmaceuticals has ended its alliance with Palatin Technologies, shortly after regulators raised 'serious concerns' over the first-in-class erectile dysfunction drug which was the subject of the collaboration... Read Cisbio to brighten screening technology Cisbio has entered into a partnership agreement with Lumiphore to gain access to new fluorescence reporter molecules for use in its high throughput (HT) screening assays... Read Antibody alternatives continue to pull in the cash Ablynx, one of the two main players in the miniature antibody sector, has signed 'by far' the biggest deal in its history, to help Boehringer Ingelheim develop up to ten so called 'Nanobodies'... Read Isis and Alnylam launch microRNA spin-out Two specialists in the field of RNA-based drug discovery have decided to launch a joint spin-out company to focus solely on microRNA (miRNA) research... Read Merck in search of Korean deal Merck & Co. is planning to reach further into the Korean market and is looking for potential deals with biotech companies in the country, according to local media... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com